A possible fresh concept in the realm of medication delivery systems is cellulose-based drug carriers. Unlike usual artificial carriers, they are biodegradable and beneficial for the environment. One naturally occurring fiber with great advantages is cellulose, derived from plants. It is easily found, biodegradable, not harmful. This essay examines many therapeutic contexts in which cellulose may be employed as a medication carrier. It discusses its attributes, how it may be altered, and how it might retain medications. Different modifications like esterification, etherification, and nanofibrillation can be done to cellulose to increase its drug-loading capacity and modulate drug release rates by means of flexibility. Making many kinds of cellulose carboxymethyl cellulose (CMC), hydroxypropyl cellulose (HPC), and cellulose nanocrystals (CNC) is made simpler by these developments. Every one of these has unique features that make them valuable for various drug transportation chores. Cellulose is an excellent choice for controlled release formulations since its changing surface chemistry also makes it superior at targeting pharmaceuticals and maintaining their stability. Moreover, cellulose-based drug carriers can be combined with other safe polymers and nanoparticles to enhance the drug packing process and thus the outcomes of treatment. Because they can be produced to do more than one thing and react to things like pH, temperature, and enzymes, cellulose-based carriers find application in many more spheres of personalized medicine. Cellulose is also reusable and is utilized again and over. For pharmaceutical firms aiming to be more environmentally friendly by utilizing less nonrenewable resources and reducing the impact of medicine delivery techniques on the surroundings, this makes it a wise decision
Keywords: Cellulose, Drug Delivery, Biodegradable, Sustainable, Nanotechnology
How to cite this article: Jagtap AD, Kumar N, Jadhav AV, Chandra PP, Bhise S, Patil BK, Cellulose-Based Drug Carriers: A Sustainable Approach .Int J Drug Deliv Technol. 2026;16(1s): 101-109 DOI: 10.25258/ijddt.16. 101-109